PMID-sentid	Pub_year	Sent_text	compound_name	comp_offset	prot_official_name	organism	prot_offset
11040018-1	2000	BACKGROUND: Two common mutations of the haemochromatosis associated gene (HFE) (cys282tyr (C282Y) and his63asp (H63D)) have been implicated in haemochromatosis and as modulators in cardiovascular disease.	cys282tyr	80-89	homeostatic iron regulator	Homo sapiens	74-77
9199565-9	1997	The cys282tyr mutation in HLA-H, a candidate gene for hh, was found in 85% of disease chromosomes.	cys282tyr	4-13	major histocompatibility complex, class I, H (pseudogene)	Homo sapiens	26-31
32329251-1	2020	BACKGROUND: A 61-year-old woman underwent direct to consumer genetic testing and was found to be homozygous for the C282Y HFE variant (c.845G>A :p.Cys282Tyr) which is classified as pathogenic/likely pathogenic for hereditary hemochromatosis.	cys282tyr	147-156	homeostatic iron regulator	Homo sapiens	122-125
9732941-2	1998	He was also found to be heterozygous for the cys282tyr mutation of the HFE gene, which is the chief cause of HLA-linked hereditary hemochromatosis (HHC).	cys282tyr	45-54	homeostatic iron regulator	Homo sapiens	71-74
34824033-3	2022	In the present review, the main aims are to show updates on hemochromatosis and to report a practical set of therapeutic recommendations for the human factors engineering protein (HFE) hemochromatosis for the p.Cys282Tyr (C282Y/C282Y) homozygous genotype, elaborated by the Haemochromatosis International Taskforce.	cys282tyr	211-220	homeostatic iron regulator	Homo sapiens	180-183